These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23260757)

  • 1. Severe phenotype of severe combined immunodeficiency caused by adenosine deaminase deficiency in a patient with a homozygous mutation due to uniparental disomy.
    Geelen J; Pfundt R; Meijer J; Verheijen FW; van Kuilenburg AB; Warris A; Marcelis C
    J Allergy Clin Immunol; 2013 Jul; 132(1):222-3. PubMed ID: 23260757
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
    Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
    J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine Deaminase Deficiency with a Novel Gene Mutation.
    Gupta M; Aluri J; Terrance A; Madkaikar M
    Indian J Pediatr; 2016 Aug; 83(8):875-6. PubMed ID: 27086606
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.
    Van Montfrans JM; Hartman EA; Braun KP; Hennekam EA; Hak EA; Nederkoorn PJ; Westendorp WF; Bredius RG; Kollen WJ; Schölvinck EH; Legger GE; Meyts I; Liston A; Lichtenbelt KD; Giltay JC; Van Haaften G; De Vries Simons GM; Leavis H; Sanders CJ; Bierings MB; Nierkens S; Van Gijn ME
    Rheumatology (Oxford); 2016 May; 55(5):902-10. PubMed ID: 26867732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous Splice ADA2 Gene Mutation Causing ADA-2 Deficiency.
    Chong-Neto HJ; Segundo GRS; Bandeira M; Chong-Silva DC; Rosário CS; Riedi CA; Hershfield MS; Ochs H; Torgerson T; Rosário NA
    J Clin Immunol; 2019 Nov; 39(8):842-845. PubMed ID: 31617030
    [No Abstract]   [Full Text] [Related]  

  • 6. Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.
    Adams SP; Wilson M; Harb E; Fairbanks L; Xu-Bayford J; Brown L; Kearney L; Madkaikar M; Bobby Gaspar H
    Clin Immunol; 2015 Dec; 161(2):174-9. PubMed ID: 26255240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of deficiency of adenosine deaminase 2 caused by CECR1 mutation with myeloablative hematopoietic stem cell transplantation].
    Song XC; Zhou F
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):509-511. PubMed ID: 32521966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADA2 deficiency due to a novel structural variation in 22q11.1.
    Grossi A; Cusano R; Rusmini M; Penco F; Schena F; Podda RA; Caorsi R; Gattorno M; Uva P; Ceccherini I
    Clin Genet; 2019 Jun; 95(6):732-733. PubMed ID: 30920658
    [No Abstract]   [Full Text] [Related]  

  • 9. A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.
    Maccora I; Frongia I; Azzari C; Ricci S; Cimaz R; Simonini G
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):146. PubMed ID: 30148442
    [No Abstract]   [Full Text] [Related]  

  • 10. Warts and DADA2: a Mere Coincidence?
    Arts K; Bergerson JRE; Ombrello AK; Similuk M; Oler AJ; Agharahimi A; Mace EM; Hershfield M; Wouters C; De Somer L; Morren MA; Diego RP; Moens L; Freeman AF; Meyts I
    J Clin Immunol; 2018 Nov; 38(8):836-843. PubMed ID: 30386947
    [No Abstract]   [Full Text] [Related]  

  • 11. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.
    Lee PY; Huang Y; Zhou Q; Schnappauf O; Hershfield MS; Li Y; Ganson NJ; Sampaio Moura N; Delmonte OM; Stone SS; Rivkin MJ; Pai SY; Lyons T; Sundel RP; Hsu VW; Notarangelo LD; Aksentijevich I; Nigrovic PA
    J Allergy Clin Immunol; 2018 Oct; 142(4):1363-1365.e8. PubMed ID: 29936104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pillars article: Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. The Lancet. 1972. 300: 1067-1069.
    Giblett ER; Anderson JE; Cohen F; Pollara B; Meuwissen HJ
    J Immunol; 2012 Feb; 188(3):936-8. PubMed ID: 22262756
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.
    Poswar Fde O; da Fonseca RM; de Albuquerque LC; Zhou Q; Jardim LB; Monte TL; Aksentijevich I; Saute JA
    J Neurol; 2016 Apr; 263(4):818-20. PubMed ID: 26914925
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
    Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
    Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency.
    Montiel-Equihua CA; Thrasher AJ; Gaspar HB
    Curr Gene Ther; 2012 Feb; 12(1):57-65. PubMed ID: 22348551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.
    Santisteban I; Arredondo-Vega FX; Kelly S; Mary A; Fischer A; Hummell DS; Lawton A; Sorensen RU; Stiehm ER; Uribe L
    J Clin Invest; 1993 Nov; 92(5):2291-302. PubMed ID: 8227344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey.
    Kisla Ekinci RM; Balci S; Hershfield M; Bisgin A; Dogruel D; Altintas DU; Yilmaz M
    Rheumatology (Oxford); 2020 Jan; 59(1):254-256. PubMed ID: 31292637
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.
    Bollinger ME; Arredondo-Vega FX; Santisteban I; Schwarz K; Hershfield MS; Lederman HM
    N Engl J Med; 1996 May; 334(21):1367-71. PubMed ID: 8614422
    [No Abstract]   [Full Text] [Related]  

  • 20. Unreported Missense Mutation in the Dimerization Domain of ADA2 Leads to ADA2 Deficiency Associated with Severe Oral Ulcers and Neutropenia in a Female Somalian Patient-Addendum to the Genotype-Phenotype Puzzle.
    Göschl L; Winkler S; Dmytrus J; Heredia RJ; Lagler H; Ramharter M; Scheinecker C; Bonelli M; Schmetterer K; Pickl WF; Grabmeier-Pfistershammer K; Hershfield MS; Boztug K; Förster-Waldl E; Gualdoni GA
    J Clin Immunol; 2020 Jan; 40(1):223-226. PubMed ID: 31686313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.